logo

For the Inventor, By the Inventor

Winnipeg, Canada

Diamedica Inc.


USPTO Granted Patents = 8



Forward Citations = 30

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Matthew Charles (3 out of 3 patents)

silverMedal Mark F Williams (3 out of 57 patents)

bronzeMedal Tadeusz Kolodka (2 out of 2 patents)

4.  Todd Verdoorn (2 out of 3 patents)

5.  Rick Pauls (2 out of 2 patents)

6.  Wilfred Wayne Lautt (1 out of 4 patents)

7.  W Wayne Lautt (1 out of 3 patents)

8.  Paula Macedo (1 out of 1 patent)

9.  Wayne W Lautt (0 patent)


8 patents:

1. 12329805 - Dosage forms of tissue kallikrein 1 (2025-06-17),
2. 11857608 - Dosage forms of tissue kallikrein 1 (2024-01-02),
3. 9839678 - Human tissue kallikrein 1 glycosylation isoforms (2017-12-12),
4. 9616015 - Formulations of human tissue kallikrein-1 for parenteral delivery and related methods (2017-04-11),
5. 9364521 - Human tissue kallikrein 1 glycosylation isoforms (2016-06-14),
6. 8673964 - Use of drug combinations for treating insulin resistance (2014-03-18),
7. 8501695 - Tissue kallikrein for the treatment of diseases associated with amyloid protein (2013-08-06),
8. 7622447 - Use of glutathione synthesis stimulating compounds in reducing insulin resistance (2009-11-24),
Diamedica is a medical technology company focused on developing innovative solutions for respiratory care. With a strong emphasis on research and development, Diamedica aims to improve patient outcomes and quality of life through cutting-edge products and technologies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

8 Patents

#21 in Winnipeg

#1,810 in Canada

...
Winnipeg, Canada

Diamedica Inc.

Forward Citations = 30

8 inventors:

goldMedal Matthew Charles (3 out of 3 patents)

silverMedal Mark F Williams (3 out of 57 patents)

bronzeMedal Tadeusz Kolodka (2 out of 2 patents)

4.  Todd Verdoorn (2 out of 3 patents)

5.  Rick Pauls (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com
Loading…